Sánchez-Rovira, P., Seguí, M. A., Llombart, A., Aranda, E., Antón, A., Sánchez, A., . . . de la Haba-Rodríguez, J. (2013). Bevacizumab plus preoperative chemotherapy in operable HER2 negative breast cancer: Biomarkers and pathologic response. Springer Milan.
Chicago Style CitationSánchez-Rovira, P., et al. Bevacizumab Plus Preoperative Chemotherapy in Operable HER2 Negative Breast Cancer: Biomarkers and Pathologic Response. Springer Milan, 2013.
MLA CitationSánchez-Rovira, P., et al. Bevacizumab Plus Preoperative Chemotherapy in Operable HER2 Negative Breast Cancer: Biomarkers and Pathologic Response. Springer Milan, 2013.
Warning: These citations may not always be 100% accurate.